AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 31(1), 1982, pp. 10-13
Copyright © 1982 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darlow, B.
Right arrow Articles by Alpers, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darlow, B.
Right arrow Articles by Alpers, M.

Sulfadoxine-Pyrimethamine for the Treatment of Acute Malaria in Children in Papua New Guinea

II. Plasmodium vivax

Brian Darlow*, Helena Vrbova, Sean Gibney, Damien Jolley, John Stace AND Michael Alpers
Papua New Guinea Institute of Medical Research, P.O. Box 378, Madang, Papua New Guinea, and Madang General Hospital, Madang, Papua New Guinea

In Papua New Guinea, Plasmodium falciparum and P. vivax are common causes of acute malaria in children and P. malariae an uncommon cause. The increasing prevelance of chloroquine-resistant strains of P. falciparum in Papua New Guinea has prompted the search for alternatives to chloroquine as standard presumptive treatment. Sulfadoxine-pyrimethamine, either alone or in combination with a single dose of chloroquine, was compared with chloroquine alone for treatment of acute vivax malaria in children in Madang. Fever resolution was slowest in the group treated with sulfadoxine-pyrimethamine alone, and time to clearance of parasitemia was significantly longer in this group (P < 0.001). Where possible, species identification should be undertaken in acute malaria and cases of P. vivax treated with chloroquine.

Accepted for publication March 28, 1981.


* Present address: Department of Paediatrics, Christchurch Hospital, Private Bag, Christchurch, New Zealand.




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey
Vivax Malaria: Neglected and Not Benign
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 79 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. Marfurt, I. Mueller, A. Sie, P. Maku, M. Goroti, J. C. Reeder, H.-P. Beck, and B. Genton
Low Efficacy of Amodiaquine or Chloroquine Plus Sulfadoxine-Pyrimethamine against Plasmodium falciparum and P. vivax Malaria in Papua New Guinea
Am J Trop Med Hyg, November 1, 2007; 77(5): 947 - 954.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. AULIFF, D. W. WILSON, B. RUSSELL, Q. GAO, N. CHEN, L. N. ANH, J. MAGUIRE, D. BELL, M. T. O'NEIL, and Q. CHENG
AMINO ACID MUTATIONS IN PLASMODIUM VIVAX DHFR AND DHPS FROM SEVERAL GEOGRAPHICAL REGIONS AND SUSCEPTIBILITY TO ANTIFOLATE DRUGS.
Am J Trop Med Hyg, October 1, 2006; 75(4): 617 - 621.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Society of Tropical Medicine and Hygiene.